Insider Trading activities of Ariad Pharmaceuticals Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ariad Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ariad Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Ariad Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ARIA. The reporting company's CIK number is 884731.
The total value of stock buying since 2005 is $9,530,946.
The total value of stock sales since 2005 is $52,752,828.
The total value of stock option exercises since 2005 is $11,507,365.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Ariad Pharmaceuticals Inc insiders (ARIA) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-04-02 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 2,400 18.04 43,296
2013-04-02 Fitzgerald Edward M (Executive VP, CFO) Sale 5,200 18.04 93,813
2013-04-02 Clackson Timothy P (President, R&D, CSO) Sale 6,500 18.04 117,247
2013-04-02 Berstein David L (Senior VP, Chief IP Officer) Sale 2,400 18.05 43,322
2013-04-01 Cantor Maria E (SVP, Corporate Affairs) Option Ex 8,500 .00 0
2013-04-01 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 8,500 .00 0
2013-04-01 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 6,000 .00 0
2013-04-01 Keane Raymond T (SVP General Counsel & CCO) Option Ex 5,166 .00 0
2013-04-01 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 6,000 .00 0
2013-04-01 Fitzgerald Edward M (Executive VP, CFO) Option Ex 13,000 .00 0
2013-04-01 Clackson Timothy P (President, R&D, CSO) Option Ex 13,000 .00 0
2013-04-01 Berstein David L (Senior VP, Chief IP Officer) Option Ex 6,000 .00 0
2013-04-01 Berger Harvey J M D (Chairman & CEO) Option Ex 41,666 .00 0
2013-03-26 Fitzgerald Edward M (Executive VP, CFO) Sale 12,933 18.75 242,493
2013-03-25 Haluska Frank (SVP, Clinical R&D, CMO) Sale 5,333 18.88 100,671
2013-03-25 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 12,933 18.87 244,084
2013-03-25 Keane Raymond T (SVP General Counsel & CCO) Sale 13,167 18.87 248,487
2013-03-25 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 8,133 18.87 153,485
2013-03-25 Clackson Timothy P (President, R&D, CSO) Sale 19,167 18.87 361,757
2013-03-25 Berstein David L (Senior VP, Chief IP Officer) Sale 10,533 18.88 198,810
2013-03-22 Cantor Maria E (SVP, Corporate Affairs) Sale 3,667 19.45 71,334
2013-03-22 Cantor Maria E (SVP, Corporate Affairs) Option Ex 18,000 .00 0
2013-03-22 Haluska Frank (SVP, Clinical R&D, CMO) Sale 2,400 19.46 46,694
2013-03-22 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 13,333 .00 0
2013-03-22 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 2,400 19.46 46,694
2013-03-22 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 32,333 .00 0
2013-03-22 Keane Raymond T (SVP General Counsel & CCO) Sale 2,334 19.46 45,421
2013-03-22 Keane Raymond T (SVP General Counsel & CCO) Option Ex 26,333 .00 0
2013-03-22 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 2,400 19.46 46,696
2013-03-22 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 20,333 .00 0
2013-03-22 Duvall Martin J (SVP, Commercial Operations) Sale 576 19.53 11,249
2013-03-22 Fitzgerald Edward M (Executive VP, CFO) Option Ex 32,333 .00 0
2013-03-22 Clackson Timothy P (President, R&D, CSO) Sale 6,667 19.46 129,719
2013-03-22 Clackson Timothy P (President, R&D, CSO) Option Ex 38,333 .00 0
2013-03-22 Berstein David L (Senior VP, Chief IP Officer) Sale 1,600 19.46 31,134
2013-03-22 Berstein David L (Senior VP, Chief IP Officer) Option Ex 26,333 .00 0
2013-03-22 Berger Harvey J M D (Chairman & CEO) Option Ex 97,667 .00 0
2013-03-20 Cantor Maria E (SVP, Corporate Affairs) Option Ex 7,334 .00 0
2013-03-20 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 6,000 .00 0
2013-03-20 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 6,000 .00 0
2013-03-20 Keane Raymond T (SVP General Counsel & CCO) Option Ex 4,667 .00 0
2013-03-20 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 6,000 .00 0
2013-03-20 Duvall Martin J (SVP, Commercial Operations) Option Ex 1,667 .00 0
2013-03-20 Fitzgerald Edward M (Executive VP, CFO) Option Ex 8,334 .00 0
2013-03-20 Clackson Timothy P (President, R&D, CSO) Option Ex 13,334 .00 0
2013-03-20 Berstein David L (Senior VP, Chief IP Officer) Option Ex 4,000 .00 0
2013-03-20 Berger Harvey J M D (Chairman & CEO) Option Ex 34,000 .00 0
2013-03-13 Berger Harvey J M D (Chairman & CEO) Sale 52,700 22.07 1,162,825
2013-03-12 Cantor Maria E (SVP, Corporate Affairs) Sale 2,105 22.00 46,310
2013-03-12 Berger Harvey J M D (Chairman & CEO) Sale 52,700 22.04 1,161,455
2013-03-04 Clackson Timothy P (President, R&D, CSO) Sale 9,838 21.00 206,598
2013-01-15 Clackson Timothy P (President, R&D, CSO) Option Ex 57,939 5.85 338,769
2013-01-02 Fitzgerald Edward M (Executive VP, CFO) Sale 25,000 20.08 501,900
2012-12-21 Lavidas Athanese (Director) Sale 10,500 20.31 213,213
2012-12-20 Clackson Timothy P (President, R&D, CSO) Option Ex 27,000 5.23 141,210
2012-12-18 Cantor Maria E (SVP, Corporate Affairs) Option Ex 12,750 .00 0
2012-12-18 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 12,750 .00 0
2012-12-18 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 9,000 .00 0
2012-12-18 Keane Raymond T (SVP General Counsel & CCO) Option Ex 7,750 .00 0
2012-12-18 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 9,000 .00 0
2012-12-18 Fitzgerald Edward M (Executive VP, CFO) Option Ex 19,500 .00 0
2012-12-18 Clackson Timothy P (President, R&D, CSO) Option Ex 19,500 .00 0
2012-12-18 Berstein David L (Senior VP, Chief IP Officer) Option Ex 9,000 .00 0
2012-12-18 Berger Harvey J M D (Chairman & CEO) Option Ex 62,500 .00 0
2012-10-01 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 7,500 25.00 187,500
2012-10-01 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2012-10-01 Lamarche Jay R (Director) Sale 10,000 24.99 249,930
2012-10-01 Fitzgerald Edward M (Executive VP, CFO) Sale 25,000 24.17 604,200
2012-09-19 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 7,500 24.00 180,000
2012-09-19 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2012-09-19 Berstein David L (Senior VP, Chief IP Officer) Sale 19,375 24.00 465,000
2012-09-19 Berstein David L (Senior VP, Chief IP Officer) Option Ex 11,375 5.23 59,491
2012-09-11 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 7,500 23.00 172,500
2012-09-11 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2012-09-11 Berstein David L (Senior VP, Chief IP Officer) Sale 38,750 23.00 891,250
2012-09-11 Berstein David L (Senior VP, Chief IP Officer) Option Ex 22,750 5.23 118,982
2012-09-06 Keane Raymond T (SVP General Counsel & CCO) Sale 10,000 22.00 220,000
2012-09-06 Keane Raymond T (SVP General Counsel & CCO) Option Ex 10,000 2.39 23,900
2012-09-06 Lamarche Jay R (Director) Option Ex 15,000 2.66 39,900
2012-09-06 Berstein David L (Senior VP, Chief IP Officer) Sale 19,375 22.00 426,250
2012-09-06 Berstein David L (Senior VP, Chief IP Officer) Option Ex 11,375 5.23 59,491
2012-09-04 Keane Raymond T (SVP General Counsel & CCO) Sale 7,780 21.00 163,380
2012-09-04 Berstein David L (Senior VP, Chief IP Officer) Sale 16,050 21.00 337,050
2012-09-04 Berstein David L (Senior VP, Chief IP Officer) Option Ex 8,050 5.23 42,101
2012-08-30 Clackson Timothy P (President, R&D, CSO) Option Ex 10,001 2.94 29,352
2012-08-15 Keane Raymond T (SVP General Counsel & CCO) Sale 10,000 20.00 200,000
2012-08-15 Keane Raymond T (SVP General Counsel & CCO) Option Ex 10,000 2.39 23,900
2012-08-15 Lamarche Jay R (Director) Sale 20,000 20.00 400,040
2012-08-15 Clackson Timothy P (President, R&D, CSO) Sale 36,843 20.00 736,860
2012-08-15 Clackson Timothy P (President, R&D, CSO) Option Ex 36,843 7.56 278,533
2012-08-15 Berstein David L (Senior VP, Chief IP Officer) Sale 8,000 20.00 160,000
2012-07-30 Cantor Maria E (SVP, Corporate Affairs) Sale 6,478 19.00 123,082
2012-07-30 Cantor Maria E (SVP, Corporate Affairs) Option Ex 6,478 7.82 50,657
2012-07-30 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 7,500 19.00 142,500
2012-07-30 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2012-07-30 Keane Raymond T (SVP General Counsel & CCO) Sale 10,000 19.00 190,000
2012-07-30 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 28,600 19.00 543,400
2012-07-30 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 25,000 5.49 137,250
2012-07-30 Clackson Timothy P (President, R&D, CSO) Sale 23,234 19.00 441,446
2012-07-30 Clackson Timothy P (President, R&D, CSO) Option Ex 23,234 5.23 121,513
2012-07-30 Berstein David L (Senior VP, Chief IP Officer) Sale 8,000 19.00 152,000
2012-07-26 Keane Raymond T (SVP General Counsel & CCO) Sale 10,000 18.00 180,000
2012-07-26 Keane Raymond T (SVP General Counsel & CCO) Option Ex 10,000 2.39 23,900
2012-07-20 Lavidas Athanese (Director) Sale 5,000 18.00 89,975
2012-07-02 Fitzgerald Edward M (Executive VP, CFO) Sale 25,000 17.64 440,950
2012-06-25 Cantor Maria E (SVP, Corporate Affairs) Sale 1,765 17.11 30,199
2012-06-22 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 7,500 17.50 131,272
2012-06-22 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2012-06-20 Lavidas Athanese (Director) Sale 5,000 17.41 87,030
2012-06-19 Cantor Maria E (SVP, Corporate Affairs) Sale 7,500 18.00 135,000
2012-06-19 Cantor Maria E (SVP, Corporate Affairs) Option Ex 7,500 3.08 23,100
2012-06-13 Berger Harvey J M D (Chairman & CEO) Option Ex 24,691 4.05 99,998
2012-06-05 Lavidas Athanese (Director) Sale 25,000 16.05 401,274
2012-06-05 Lavidas Athanese (Director) Option Ex 25,000 6.39 159,750
2012-05-21 Lavidas Athanese (Director) Sale 5,000 16.54 82,690
2012-05-21 Berstein David L (Senior VP, Chief IP Officer) Sale 26,075 16.54 431,384
2012-05-21 Berstein David L (Senior VP, Chief IP Officer) Option Ex 26,075 4.19 109,254
2012-05-16 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 22,130 17.50 387,275
2012-05-03 Fitzgerald Edward M (Executive VP, CFO) Option Ex 60,000 4.63 277,800
2012-05-02 Haluska Frank (SVP, Clinical R&D, CMO) Sale 3,000 17.00 51,000
2012-05-02 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 3,000 2.39 7,170
2012-05-02 Clackson Timothy P (President, R&D, CSO) Sale 20,000 17.00 340,000
2012-05-02 Clackson Timothy P (President, R&D, CSO) Option Ex 20,000 7.44 148,800
2012-05-02 Berstein David L (Senior VP, Chief IP Officer) Sale 19,375 17.00 329,375
2012-05-02 Berstein David L (Senior VP, Chief IP Officer) Option Ex 11,375 4.19 47,661
2012-04-20 Lavidas Athanese (Director) Sale 10,000 15.06 150,560
2012-04-17 Fitzgerald Edward M (Executive VP, CFO) Sale 40,000 15.00 600,000
2012-04-17 Fitzgerald Edward M (Executive VP, CFO) Option Ex 40,000 4.63 185,200
2012-04-17 Clackson Timothy P (President, R&D, CSO) Sale 7,111 15.00 106,665
2012-04-13 Clackson Timothy P (President, R&D, CSO) Sale 31,600 14.83 468,628
2012-04-12 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 17,062 15.39 262,584
2012-04-09 Lavidas Athanese (Director) Sale 15,000 15.76 236,355
2012-04-03 Cantor Maria E (SVP, Corporate Affairs) Sale 3,400 16.18 55,025
2012-04-03 Haluska Frank (SVP, Clinical R&D, CMO) Sale 4,250 16.18 68,765
2012-04-03 Keane Raymond T (SVP General Counsel & CCO) Sale 2,067 16.18 33,454
2012-04-03 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 2,400 16.18 38,836
2012-04-03 Fitzgerald Edward M (Executive VP, CFO) Sale 5,200 16.18 84,156
2012-04-03 Clackson Timothy P (President, R&D, CSO) Sale 5,200 16.18 84,136
2012-04-03 Berstein David L (Senior VP, Chief IP Officer) Sale 2,400 16.18 38,844
2012-04-02 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 10,667 16.11 171,888
2012-04-02 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 10,667 7.82 83,415
2012-04-01 Cantor Maria E (SVP, Corporate Affairs) Option Ex 8,500 .00 0
2012-04-01 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 8,500 .00 0
2012-04-01 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 6,000 .00 0
2012-04-01 Keane Raymond T (SVP General Counsel & CCO) Option Ex 5,167 .00 0
2012-04-01 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 6,000 .00 0
2012-04-01 Fitzgerald Edward M (Executive VP, CFO) Option Ex 13,000 .00 0
2012-04-01 Clackson Timothy P (President, R&D, CSO) Option Ex 13,000 .00 0
2012-04-01 Berstein David L (Senior VP, Chief IP Officer) Option Ex 6,000 .00 0
2012-04-01 Berger Harvey J M D (Chairman & CEO) Option Ex 41,667 .00 0
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of ARIA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ariad Pharmaceuticals Inc (symbol ARIA, CIK number 884731) see the Securities and Exchange Commission (SEC) website.